Skip to content
Jiaqi Zheng 郑嘉齐 – Primavera Capital

Jiaqi Zheng


Jiaqi is a founding member of Primavera Capital Group. He leads or co-leads the firm’s investments in healthcare and TMT sectors.

Jiaqi led or played an important role in a broad range of investment deals including ByteDance, LBX Pharmacy Chain, Jenscare Biotechnology, Avistone Pharmaceuticals, OptoMedic, Shukun Technology, Asia Medical, Symap Medical, OASIS International Hospital, Ubox Technology, as well as the cross-border joint acquisition of Iovate Health Sciences and the privatization of Shanda Games, Focus Media and Chemspec. He currently serves on the boards of LBX Pharmacy Chain, Jenscare Biotechnology, Avistone Pharmaceutical, Asia Medical and Iovate Health Sciences.

He previously worked at the Investment Banking Department of China International Capital Corporation.

Jiaqi holds a Bachelor of Arts in Economics from the University of Manchester and a Master of Science in Finance from Lancaster University.